Clinical Trials Related to Hematological Malignancies

Related studies linked through entity extraction aliases.

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies

Status: COMPLETED
Phase: PHASE1

Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK in Patients With Haematological Malignancies

Status: COMPLETED
Phase: PHASE1/PHASE2

Nonmyeloablative Stem Cell Transplant in Elderly

Status: COMPLETED
Phase: PHASE2/PHASE3

Rituximab for Prevention of Chronic GVHD

Status: COMPLETED
Phase: PHASE1/PHASE2

An Evaluation of the Effect of 'Open Window' on Psychological Well-being and Experience of Stem Cell Transplantation

Status: COMPLETED
Phase: NA

Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])

Status: COMPLETED
Phase: NA

RCT to Investigate Whether an Exercise Programme Improves the Physical Performance and QOL After BMT

Status: UNKNOWN
Phase: NA

MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

Status: UNKNOWN
Phase: PHASE2

STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors

Status: COMPLETED
Phase: PHASE1

Study of ABT-751 in Patients With Refractory Hematologic Malignancies

Status: COMPLETED
Phase: PHASE1